Tony Abbott backs legalisation of medical cannabis

By Matthew Knott
Updated October 11 2014 - 10:13am, first published September 18 2014 - 2:58am
Tony Abbott says he has "no problem" with the medical use of cannabis. Photo: AFR
Tony Abbott says he has "no problem" with the medical use of cannabis. Photo: AFR
Tony Abbott says he has "no problem" with the medical use of cannabis. Photo: AFR
Tony Abbott says he has "no problem" with the medical use of cannabis. Photo: AFR
Tony Abbott says he has "no problem" with the medical use of cannabis. Photo: AFR
Tony Abbott says he has "no problem" with the medical use of cannabis. Photo: AFR
Tony Abbott says he has "no problem" with the medical use of cannabis. Photo: AFR
Tony Abbott says he has "no problem" with the medical use of cannabis. Photo: AFR
Dan Haslam has been using cannabis to relieve nausea associated with chemotheraphy treatment. Photo: Geoff O'Neill
Dan Haslam has been using cannabis to relieve nausea associated with chemotheraphy treatment. Photo: Geoff O'Neill

Prime Minister Tony Abbott has thrown his support behind the legalisation of cannabis for medical purposes.

In a letter to talkback radio host Alan Jones, Mr Abbott went even further than NSW Premier Mike Baird – who has approved a clinical trial of the use of medical cannabis – by saying that no further testing should be needed on the drug if it is legal in similar jurisdictions.

"I have no problem with the medical use of cannabis, just as I have no problem with the medical use of opiates," Mr Abbott wrote in a letter to Jones dated August 23.

"I was under the impression that the personal use of cannabis was no longer an offence in NSW.

"If a drug is needed for a valid medicinal purpose though and is being administered safely there should be no question of its legality. And if a drug that is proven to be safe abroad is needed here it should be available.

"I agree that the regulation of medicines is a thicket of complexity, bureaucracy and corporate and institutional self interest.

"My basic contention is that something that has been found to be safe in a reliable jurisdiction shouldn't need to be tested again here."

Jones read out the letter from Mr Abbott – who has not commented publicly on the issue before – on his 2GB breakfast program on Wednesday. The influential presenter has been campaigning on behalf of 24-year-old Dan Haslam, who has been using cannabis to relieve nausea associated with chemotherapy to treat his terminal cancer.

Mr Abbott's intervention was welcomed by Mr Haslam's mother, Lucy, who has launched a popular online petition to decriminalise cannabis for pain relief.

Mr Baird announced on Tuesday that a clinical trial into medical cannabis will report back to the government by the end of the year.

He also told the NSW Parliament that he would formalise new guidelines to clarify the NSW police discretion to not charge terminally ill adults if they are caught using cannabis for pain relief.

In Victoria, state Opposition Leader Daniel Andrews has promised to legalise access to medical marijuana for Victorians with life-threatening conditions if Labor wins office in November.

He made an election promise last month to seek advice from the Victorian Law Reform Commission on how people "in exceptional circumstances" could get the drug.

The commission would be asked to report back on how the prescription, manufacture and distribution of medical cannabis could be regulated by August next year.

While the plan opens up the possibility of approved people growing their own cannabis or being protected from criminal charges for possessing it, Victorian Health Minister David Davis said he would only allow more clinical trials of cannabis-based pharmaceuticals.

This is how Sativex – a cannabis-derived mouth spray approved for people with multiple sclerosis – became available in Australia.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Wodonga news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.